In cohort-1, plasma BD-tau (Fig. 2A), but not plasma t-tau (Fig. 2B) or NfL (Fig. 2C), was significantly associated with future AD meta-Region of Interest (ROI) atrophy (b = −0.06, p < 0.01; Supplementary Table 3). Here, MAPT is linked to Alzheimer disease.